Apervita

About Apervita

Apervita, Inc., initially known as Pervasive Health, was established in Chicago, Illinois in 2011 by founder Paul Magelli. The company operated as a healthcare technology firm focused on value-based healthcare, providing a collaboration platform for payers, providers, and other healthcare stakeholders. Over its history, Apervita raised a total of $43.5 million in funding over six rounds from investors including Baird Capital, General Electric, and Pritzker Group.

The company's core business centered on a secure, HIPAA-compliant cloud platform that enabled health enterprises to digitize and commercialize their medical intellectual property. This platform allowed users to share and analyze health data related to patient outcomes, utilization, and costs, transforming it into computable insights. The goal was to help healthcare organizations measure clinical and financial performance, improve quality of care, and manage value-based contracts more effectively. Apervita's offerings included tools for readmission prevention, chronic disease management, and compliance. The business model involved a marketplace where institutions and researchers could publish and sell their data-driven medical algorithms.

In August 2019, Apervita merged with Boston-based Qcentive, a company specializing in the administration of value-based contracts. Following this merger, Kevin Hutchinson, a seasoned healthcare technology executive and the founding CEO of Surescripts, was appointed as Apervita's CEO. A significant development occurred in August 2021 when Clarify Health acquired Apervita's value optimization business, including all related intellectual property and employees. After this acquisition, Apervita planned to refocus its efforts on providing solutions for digital quality measurement and clinical intelligence. However, according to PitchBook data, the company was reported as out of business as of October 6, 2021.